Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore A Vandenberg

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Anticancer Research|August 6, 2005
A practical overview of aromatase inhibitorsJawaid Younus, Theodore A Vandenberg
Bulletin Du Cancer|May 13, 2005
A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancerJawaid Younus, Theodore A Vandenberg
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
Caution with breast-conserving surgeryTheodore A Vandenberg, Vivian H Bramwell
Breast Cancer Research : BCR|February 25, 2011
Gene signatures of breast cancer progression and metastasisDavid I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Serial plasma osteopontin levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 26, 2008
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Breast Cancer Research and Treatment|April 13, 2013
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapyWendy A Teft, Inna Y Gong, Brian Dingle, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Anticancer Research|August 6, 2005
A practical overview of aromatase inhibitorsJawaid Younus, Theodore A Vandenberg
Bulletin Du Cancer|May 13, 2005
A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancerJawaid Younus, Theodore A Vandenberg
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
Caution with breast-conserving surgeryTheodore A Vandenberg, Vivian H Bramwell
Breast Cancer Research : BCR|February 25, 2011
Gene signatures of breast cancer progression and metastasisDavid I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Serial plasma osteopontin levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 26, 2008
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancerVivien H C Bramwell, Gordon S Doig, Alan B Tuck, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Breast Cancer Research and Treatment|April 13, 2013
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapyWendy A Teft, Inna Y Gong, Brian Dingle, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Pageof 2